Cargando…

Rates of complete diagnostic testing for patients with acute myeloid leukemia

In addition to cytogenetics, additional molecular markers of prognosis have been identified and incorporated into the management of patients with acute myeloid leukemia (AML). We hypothesized that rates of molecular testing would be higher in an academic center versus community sites. A retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Tara L, Williams, Travis, He, Jianghua, Aljitawi, Omar S, Ganguly, Siddhartha, Abhyankar, Sunil, Fleming, Allan, Male, Heather, McGuirk, Joseph P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402066/ https://www.ncbi.nlm.nih.gov/pubmed/25620650 http://dx.doi.org/10.1002/cam4.406

Ejemplares similares

Bendamustine Associated with Irreversible Ascending Paralysis
por: Alhafez, Ashraf, et al.
Publicado: (2013)

Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism
por: Pawar, Rahul, et al.
Publicado: (2014)

Clinical characteristics and treatment outcome of patients with isochromosome 17q (i17q) abnormality and myeloid neoplasms: A single center experience
por: Ganguly, Siddhartha, et al.
Publicado: (2018)

Inflammatory response following neutrophil recovery postchemotherapy in acute myeloid leukemia cases without evidence of infection: role of homing of neutrophils
por: Pawar, Rahul D, et al.
Publicado: (2014)

The Potential Role of 3D In Vitro Acute Myeloid Leukemia Culture Models in Understanding Drug Resistance in Leukemia Stem Cells
por: Al-Kaabneh, Basil, et al.
Publicado: (2022)

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia
por: Ganguly, Siddhartha, et al.
Publicado: (2015)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
por: Gil, Kellen, et al.
Publicado: (2022)

WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
por: Li, Meizhang, et al.
Publicado: (2021)

“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy
por: Ahmed, Nausheen, et al.
Publicado: (2023)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway
por: Chen, Yanli, et al.
Publicado: (2022)

B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015)

Functional characterization of NPM1–TYK2 fusion oncogene
por: Kuravi, Sudhakiranmayi, et al.
Publicado: (2022)

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia
por: Faisal, Muhammad, et al.
Publicado: (2019)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Radical cities : across Latin America in search of a new architecture
por: McGuirk, Justin
Publicado: (2014)

Ciudades radicales : un viaje a la nueva arquitectura latinoamericana /
por: McGuirk, Justin
Publicado: (2015)

Radical cities : across Latin America in search of a new architecture /
por: McGuirk, Justin
Publicado: (2015)

Performing social media analytics with Brandwatch for Classrooms: a platform review
por: McGuirk, Mike
Publicado: (2021)

Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation
por: McGuirk, Joseph, et al.
Publicado: (2009)

Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia
por: Sadashiv, Santhosh K, et al.
Publicado: (2014)

Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine
por: Shao, Jianming, et al.
Publicado: (2023)

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group
por: Nagarajan, Rajaram, et al.
Publicado: (2019)

Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2021)

The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
por: Pellicano, Francesca, et al.
Publicado: (2014)

Disease Management of Dairy Calves and Heifers
por: McGuirk, Sheila M.
Publicado: (2008)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
por: Takao, Sumiko, et al.
Publicado: (2021)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

Prognostic significance of CXCR4 expression in acute myeloid leukemia
por: Du, Wen, et al.
Publicado: (2019)

Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway
por: Zhou, Pan, et al.
Publicado: (2019)

LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor
por: Zhang, Peng, et al.
Publicado: (2019)

Deep molecular responses for treatment‐free remission in chronic myeloid leukemia
por: Dulucq, Stéphanie, et al.
Publicado: (2016)

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)

Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells
por: Domingues, Ana Filipa, et al.
Publicado: (2020)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia
por: Shao, Jianming, et al.
Publicado: (2023)

CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
por: Kuravi, Sudhakiranmayi, et al.
Publicado: (2019)

Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
por: Abdallah, Al‐Ola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ra5f6j2cue7isjrqb4gdl3og3s